PubRank

Study Comparing Bone Loss in Women Who Take Calcium and Vitamin D With Women Who Also Take Risedronate or Exercise (HOPE)

Clinical Trial ID NCT02186600

PubWeight™ 0.75‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02186600

Top papers

Rank Title Journal Year PubWeight™‹?›
1 American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011 14.42
2 Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006 10.95
3 Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005 5.95
4 Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010 2.53
5 Interpretation and use of FRAX in clinical practice. Osteoporos Int 2011 2.43
6 Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr 2006 1.57
7 Long-term safety of bisphosphonates. J Clin Endocrinol Metab 2005 1.50
8 Transmenopausal changes in the trabecular bone structure. Bone 2007 1.46
9 Extending DXA beyond bone mineral density: understanding hip structure analysis. Curr Osteoporos Rep 2007 1.32
10 Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. Bone 2004 1.27
11 Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate. Geriatrics 2006 1.22
12 Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res 2009 0.92
13 An exercise intervention for breast cancer survivors with bone loss. J Nurs Scholarsh 2009 0.92
14 The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women. Bone 2006 0.90
15 Effects of microarchitecture on bone strength. Curr Osteoporos Rep 2007 0.90
16 Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitom 2002 0.89
17 Long-Term Alendronate Use Not without Consequences? Int J Rheumatol 2010 0.82
18 Biochemical markers of bone turnover and their utility in osteoporosis. MLO Med Lab Obs 2004 0.81
19 Does frequency of resistance training affect tibial cortical bone density in older women? A randomized controlled trial. Osteoporos Int 2012 0.75
20 Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women. BMC Womens Health 2016 0.75
Next 100